PARENKUMAR PATEL: Open Payments
NPI 1760613012 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 48 payments from 17 companies in 2025. Trend: 2023 $860 · 2024 $730 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $188 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| Lilly USA, LLC | 5 | $122 |
| PFIZER INC. | 6 | $119 |
| SHIELD THERAPEUTICS INC | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Corcept Therapeutics | 2 | $46 |
| ABBVIE INC. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Itamar Medical Inc | 1 | $28 |
Products named: Ozempic, FARXIGA, MOUNJARO, AIRSUPRA, ACCRUFER, Wegovy, Kerendia, JARDIANCE.
Industry payments across FL — which companies pay providers there.
